dc.creator | Bollini, Mariela | |
dc.creator | Gallardo Macias, Ricardo | |
dc.creator | Spasov, Krasimir A. | |
dc.creator | Tirado Rives, Julian | |
dc.creator | Anderson, Karen S. | |
dc.creator | Jorgensen, William L. | |
dc.date.accessioned | 2017-08-23T19:32:18Z | |
dc.date.accessioned | 2018-11-06T14:36:49Z | |
dc.date.available | 2017-08-23T19:32:18Z | |
dc.date.available | 2018-11-06T14:36:49Z | |
dc.date.created | 2017-08-23T19:32:18Z | |
dc.date.issued | 2012-12 | |
dc.identifier | Bollini, Mariela; Gallardo Macias, Ricardo; Spasov, Krasimir A.; Tirado Rives, Julian; Anderson, Karen S.; et al.; Optimization of benzyloxazoles as non-nucleoside inhibitors of HIV-1 reverse transcriptase to enhance Y181C potency; Elsevier; Bioorganic & Medicinal Chemistry Letters; 23; 4; 12-2012; 1110-1113 | |
dc.identifier | 0960-894X | |
dc.identifier | http://hdl.handle.net/11336/22884 | |
dc.identifier | CONICET Digital | |
dc.identifier | CONICET | |
dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/1888260 | |
dc.description.abstract | Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved activity towards Tyr181Cys containing variants was pursued with the assistance of free energy perturbation (FEP) calculations. Optimization of the 4-R substituent in 1 led to ethyl and isopropyl analogs 1e and 1f with 1–7 nM potency towards both the wild-type virus and a Tyr181C variant. | |
dc.language | eng | |
dc.publisher | Elsevier | |
dc.relation | info:eu-repo/semantics/altIdentifier/url/http://www.sciencedirect.com/science/article/pii/S0960894X12015673 | |
dc.relation | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.bmcl.2012.11.115 | |
dc.rights | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.subject | Anti-HIV agents | |
dc.subject | Computer-aided drug design | |
dc.subject | Free-energy calculations | |
dc.subject | NNRTIs | |
dc.title | Optimization of benzyloxazoles as non-nucleoside inhibitors of HIV-1 reverse transcriptase to enhance Y181C potency | |
dc.type | Artículos de revistas | |
dc.type | Artículos de revistas | |
dc.type | Artículos de revistas | |